Éragny-sur-Oise, France, June 18, 2021 5:35 pm – Safe (FR0013467123 – ALSAF), a company specializing in the design, manufacture and commercialization of ready-to-use technologies for back surgery, with particular emphasis on the treatment of emergency vertebral fractures, announced that the Ordinary and Extraordinary Annual General Meeting of Shareholders was held this Friday, June 18, 2021 at 9:30 am behind closed doors at the company’s headquarters.
It is recalled that under an order of the President of the Commercial Court of Pontoise dated June 16, 2021, Maître Florence TULIER had been appointed as ad hoc representative with the mission of representing defaulting shareholders at the general meeting. .
The general meeting adopted all the resolutions in accordance with the recommendations of the board of directors of the company. In particular, the general meeting approved the annual accounts for the year ended December 31, 2020.
The results of the votes will be available in the coming days on the company’s website (www.safeorthopaedics.com/investisseurs/documentation/ section “General Meeting”).
About the Safe Group
The Safe Group is a French medical technology group that brings together Safe Orthopedics, a pioneer in ready-to-use technologies for spinal pathologies, and Safe Medical (formerly LCI Medical), a subcontractor of medical devices for orthopedic surgery. The group employs around 150 people.
Safe Orthopedics develops and manufactures kits combining sterile implants and single-use instruments, available to the surgeon at any time. These technologies are part of a minimally invasive approach aimed at reducing the risks of contamination and infection, for the benefit of the patient and with a positive impact on the delays and costs of hospitalization. Protected by 18 patent families, SteriSpineMT kits are CE marked and FDA approved. Safe Orthopedics is headquartered in the Paris region (95610 Eragny sur Oise – France) and has subsidiaries in the United Kingdom, Germany, the United States and in the Lyon region where the manufacturing company is located.
For more information: www.SafeOrthopaedics.com
Safe Medical (formerly LCI Medical) produces implantable medical devices and ready-to-use instruments. It has an innovation center and two production sites in France and Tunisia, offering many industrial services: design, industrialization, machining, finishing and sterile packaging. Supported by the French recovery plan in 2020, the company is investing in additive printing and will be operational in 2022 with this new technology.
For more information: www.safemedical.fr
Financial and Administrative Director
Phone: +33 (0) 1 34 21 50 00
Pierre-Louis Germain / +33 (0) 6 64 79 97 61 / firstname.lastname@example.org
Bruno Arabian / +33 (0) 6 87 88 47 26 / email@example.com